Aspira Pathlab & Diagnostics Ltd — Important, 01-01-1970: Company Update

Aspira Pathlab & Diagnostics Limited is targeted by an open offer from a group of acquirers and a Person Acting in Concert (PAC) to buy up to 26.76 lakh equity shares, or 26% of voting capital, at ₹55 per share in cash. This aims to consolidate promoter group holdings and increase their control, with a maximum consideration of ₹14.72 Cr. After the offer, acquirers and PAC would collectively own 49.82%. The company's shares are BSE-listed, and the acquirers plan to retain this status. Financials show FY25 operating income at ₹21.99 Cr (profit ₹2.02 Cr) and the recent quarter's operating income at ₹5.25 Cr (profit ₹0.42 Cr). Independent directors will share their view on the offer.